Formycon AG in 1 story
The narratives FYB.DE currently appears in, with its side and exposure in each.
Bull side
1 story- America Imports the World's Drug Prices
FYB.DE in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Formycon's focused biosimilar pipeline directly addresses high-cost branded biologics whose economics are threatened by stricter price comparisons.
Bear side
0 storiesNo bear-side stories for FYB.DE yet.